PMA device
Lsc Total Knee System
Depuy, Inc. · Prosthesis, Knee, Patellofemorotibial, Semi-Constrained, Metal/Polymer, Mobile Bearing (NJL, Class III) · First FDA decision Nov 29, 2013, newest Nov 29, 2013Knee osteoarthritis
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
5
Naming "Lsc"
MAUDE reports
0
Brand "Lsc", since 2015
PubMed studies
6,773
Mentioning "Lsc"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Lsc Total Knee System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 0 of 1 decisions filed under this name.
FDA's records could not be loaded.
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Lsc", any status and sponsor, newest update first.
- Pretreatment to Promote Graft Survival After Subsequent High-risk Corneal Transplantation [CrossCornealVision]Pivotal-lookingRecruiting
Claus CursiefenAcademic, hospital or other
NCT05870566 · 110 participants (planned) · Start Nov 20, 2023 · Primary completion Sep 30, 2027
Device: Corneal Crosslinking · For: Corneal Transplantation
Sites: München, Germany; Cologne, Germany; Düsseldorf, Germany · 7 sites in all
Children's Hospital Los AngelesAcademic, hospital or other
NCT03954223 · 50 participants · Start Mar 1, 2020 · Primary completion Jan 30, 2022
Device: Continuous Glucose Monitor · For: Obesity, Childhood
Sites: Los Angeles, California
The University of Texas Health Science Center, HoustonAcademic, hospital or other
NCT02340650 · 37 participants · Start Apr 2015 · Primary completion Sep 30, 2020
Device: Standard High Resolution Microendoscope and/or Line-Scanning Confocal High Resolution Microendoscope · For: Bladder Cancer
Sites: Houston, Texas
2 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Lsc", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code NJL
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Lsc"[tiab]. The summary above synthesizes these.
- Leukemic stem cells and therapy resistance in acute myeloid leukemia.
Stelmach P, Trumpp A · Haematologica · 2023Review, Research Support, Non-U.S. Gov't
- Limbal stem cell therapy.
Bonnet C, Gonzalez S, Deng SX · Curr Opin Ophthalmol · 2024Review
- Leukemia stem cells.
Lane SW, Gilliland DG · Semin Cancer Biol · 2010Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- A Novel Type of Monocytic Leukemia Stem Cell Revealed by the Clinical Use of Venetoclax-Based Therapy.
Pei S, Shelton IT, Gillen AE, et al. · Cancer Discov · 2023Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- Inhalation of lung spheroid cell secretome and exosomes promotes lung repair in pulmonary fibrosis.
Dinh PC, Paudel D, Brochu H, et al. · Nat Commun · 2020Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- [Scleroderma].
Scharffetter K, Kind P, Wollny-Protzel D, et al. · Z Hautkr · 1990English Abstract, Review
- Chronic myeloid leukemia stem cells.
Houshmand M, Simonetti G, Circosta P, et al. · Leukemia · 2019Research Support, Non-U.S. Gov't, Review
- A Dynamic rRNA Ribomethylome Drives Stemness in Acute Myeloid Leukemia.
Zhou F, Aroua N, Liu Y, et al. · Cancer Discov · 2023Research Support, Non-U.S. Gov't
- Primary Human Leukemia Stem Cell (LSC) Isolation and Characterization.
Meriç N, Kocabaş F · Methods Mol Biol · 2024Research Support, Non-U.S. Gov't
- Leukemia stem cells.
Buss EC, Ho AD · Int J Cancer · 2011Review
- Identification of leukemia stem cell subsets with distinct transcriptional, epigenetic and functional properties.
Boutzen H, Murison A, Oriecuia A, et al. · Leukemia · 2024Research Support, Non-U.S. Gov't
- RAB27B-regulated exosomes mediate LSC maintenance via resistance to senescence and crosstalk with the microenvironment.
Chen Y, Wen J, Li Q, et al. · Leukemia · 2024Research Support, Non-U.S. Gov't
Other devices of this type
Also filed under product code NJL.
- LCS® Total Knee SystemDepuy, Inc. · PMA 2024
- Zimmer Nexgen Lps-Flex Mobile and Lps-Mobile Bearing Knee SystemZimmer, Inc. · PMA 2016
- Attune Revision Knee SystemDepuy, Inc. · PMA 2026
- ATTUNE Revision Rotating Platform (RP) Knee SystemDepuy, Inc. · PMA 2025
- ATTUNETM Rotating Platform (RP) Total Knee SystemDepuy, Inc. · PMA 2025
- Attune Primary SystemDepuy, Inc. · PMA 2025
- NexGen LPS-Flex/LPS Mobile Bearing Knee SystemZimmer, Inc. · PMA 2021
- Flex Mobile Bearing KneeZimmer, Inc. · PMA 2011
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.